Table 1. Comparison of demographic data and YAP expression between type 1 and type 2 EMCA.

		Type1 cancer (n = 120)	Type2 cancer (n = 30)	P-value
Age (year)	mean (range)	63.6 (40–89)	67.4 (47–85)	N.S.(a)
BMI	mean (range)	36.8 (19.1–70.4)	35 (18.4–85.4)	N.S.(a)
Ethnic group	White	119	29
	Other races	1	1	N.S.(b)
Grade	1	103	0
	2/3	17	30	p<0.0001(b)
Stage	I/II	53	56
	III/IV	1	10	p = 0.028(b)
LVSI	Absent	99	13
	Present	21	17	p<0.0001(b)
Recurrence/Metastasis	Absent	110	17
	Present	10	13	p<0.0001(b)
Nuclear YAP score	0	23	1
	1	31	2
	2	20	8
	3	16	7
	4	30	12
	Low (score: 0/1)	54	3
	High (score: 2/3/4)	66	27	p = 0.0009(b)
Cytoplasmic YAP score	0	3	0
	1	14	0
	2	21	11
	3	40	9
	4	42	10
	Low (score: 0/1/2)	38	11
	High (score: 3/4)	82	19	N.S.(b)

BMI; Body mass index, LVSI; Lymphovascular space involvement, N.S.; not significant.

(a): Student's t-test, (b): Chi square test (there is no <10 number in data)/Fisher's exact test (there is <10 number in data).